Ahlam Qerqez

Technologies

• Engineered antibodies for enhanced immune response
• Dual-target antibody toolkit for overcoming resistance in anti-angiogenic cancer therapy
• Engineered T-cell receptor platforms for targeted detection and treatment of cytomegalovirus-infected cells